MUGEN ESTATE Co.,Ltd.

TSE:3299 Voorraadrapport

Marktkapitalisatie: JP¥36.6b

MUGEN ESTATELtd Toekomstige groei

Future criteriumcontroles 1/6

MUGEN ESTATELtd's earnings are forecast to decline at 0.5% per annum while its annual revenue is expected to grow at 16.2% per year. EPS is expected to decline by 0.4% per annum.

Belangrijke informatie

-0.5%

Groei van de winst

-0.4%

Groei van de winst per aandeel

Real Estate winstgroei6.0%
Inkomstengroei16.2%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt07 Mar 2024

Recente toekomstige groei-updates

Recent updates

MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

Sep 23
MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

Sep 09
MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

MUGEN ESTATE Co.,Ltd. (TSE:3299) Shares Fly 29% But Investors Aren't Buying For Growth

Sep 01
MUGEN ESTATE Co.,Ltd. (TSE:3299) Shares Fly 29% But Investors Aren't Buying For Growth

MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

Aug 26
MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

Aug 12
MUGEN ESTATELtd (TSE:3299) Is Increasing Its Dividend To ¥68.00

Should You Be Adding MUGEN ESTATELtd (TSE:3299) To Your Watchlist Today?

Aug 03
Should You Be Adding MUGEN ESTATELtd (TSE:3299) To Your Watchlist Today?

We Ran A Stock Scan For Earnings Growth And MUGEN ESTATELtd (TSE:3299) Passed With Ease

Mar 19
We Ran A Stock Scan For Earnings Growth And MUGEN ESTATELtd (TSE:3299) Passed With Ease

MUGEN ESTATE Co.,Ltd. (TSE:3299) Stock Rockets 27% But Many Are Still Ignoring The Company

Feb 26
MUGEN ESTATE Co.,Ltd. (TSE:3299) Stock Rockets 27% But Many Are Still Ignoring The Company

Winst- en omzetgroeiprognoses

TSE:3299 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202572,2004,620N/AN/A1
12/31/202461,4004,090N/AN/A1
6/30/202456,8954,7885211,164N/A
3/31/202452,3203,459N/AN/AN/A
12/31/202351,6403,6534,8595,374N/A
9/30/202349,5263,594N/AN/AN/A
6/30/202343,4832,905-1,531-1,443N/A
3/31/202338,1542,301N/AN/AN/A
12/31/202231,2421,564-11,646-11,491N/A
9/30/202229,1241,222N/AN/AN/A
6/30/202230,1671,127-11,466-10,254N/A
3/31/202228,4301,036N/AN/AN/A
12/31/202133,9561,2762,1353,307N/A
9/30/202139,5421,702N/AN/AN/A
6/30/202138,3911,00317,95818,717N/A
3/31/202135,801696N/AN/AN/A
12/31/202034,8585999,19410,981N/A
9/30/202031,496143N/AN/AN/A
6/30/202035,1421,115-3,890-2,073N/A
3/31/202040,1491,554N/AN/AN/A
12/31/201939,6771,6882,4873,276N/A
9/30/201947,2212,848N/AN/AN/A
6/30/201948,0972,85112,53112,585N/A
3/31/201950,1182,904N/AN/AN/A
12/31/201853,9313,356-7,287-7,220N/A
9/30/201851,4022,865N/AN/AN/A
6/30/201856,6233,462-14,464-14,377N/A
3/31/201861,4894,062N/AN/AN/A
12/31/201763,5684,276N/A7,266N/A
9/30/201764,1943,622N/AN/AN/A
6/30/201762,5313,376N/A1,929N/A
3/31/201760,2043,167N/AN/AN/A
12/31/201657,4882,925N/A-8,723N/A
9/30/201654,9183,769N/AN/AN/A
6/30/201651,8253,682N/A-7,787N/A
3/31/201649,2233,608N/AN/AN/A
12/31/201545,7063,382N/A-7,292N/A
9/30/201540,6092,791N/AN/AN/A
6/30/201536,4812,510N/A-10,396N/A
3/31/201531,4941,920N/AN/AN/A
12/31/201430,1751,759N/A-6,444N/A
12/31/201320,8301,127N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 3299's earnings are forecast to decline over the next 3 years (-0.5% per year).

Winst versus markt: 3299's earnings are forecast to decline over the next 3 years (-0.5% per year).

Hoge groeiwinsten: 3299's earnings are forecast to decline over the next 3 years.

Omzet versus markt: 3299's revenue (16.2% per year) is forecast to grow faster than the JP market (4.2% per year).

Hoge groei-inkomsten: 3299's revenue (16.2% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if 3299's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y